Christopher M. Counter, Ph.D.
Principle Investigator
George Barth Geller Distinguished Professor of Pharmacology & Cancer Biology
Ryne Ramaker, M.D., Ph.D.
Postdoctoral fellow developing platforms to detect pancreatic cancer and to understand the origins of this disease.
Yuchen Zhang, Ph.D.
Postdoctoral fellow exploring how specific oncogenic mutations arise and are selected to initiate tumorigenesis using novel mouse models and ultra-sensitive sequencing.
Seth Zimmerman, Ph.D.
Postdoctoral fellow utilising proteomics to elucidate how onconfusions promote childhood solid cancer rhabdomyosarcoma.
Anicka AbiChedid
Ph.D. student exploring how cancer-causing mutations are generated to initiate tumorigenesis using ultra-sensitive sequencing platforms.
Taylor Niehoff
Ph.D. student exploring how the poor expression of oncogenic KRAS imposed by rare codons is overcome by undertaking CRISPR/Cas9 loss-of-function screens for modifiers of rare codon-dependent expression.
Patrick Prochazka
Ph.D. student exploring how specific mutations are selected during the process of tumor initiation and promotion in vivo.
Wenceslaus Githiiyi
Technician aiding studies into the origin of cancer using ultra-sensitive sequencing and genetically engineered mouse models of cancer